Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients

Aims Mitogen-activated protein kinase (MAPK) pathway alteration is a major oncogenic driver in paediatric low-grade gliomas (LGG) and some adult gliomas, encompassing BRAF (most common) and non-BRAF alterations. The aim was to determine the frequency, molecular spectrum and clinicopathological featu...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Ahmed, Amir A. (author)
مؤلفون آخرون:	Alateeqi, Mona (author), Ali, Nawal Y. (author), Ali, Rola H. (author), Almanabri, Mohamad (author), Almarzooq, Ammar (author), Almurshed, Maryam (author), Alqallaf, Zainab (author), Alsaber, Ahmad (author), Bahzad, Shakir (author), Benobaid, Noelle (author), Hussein, Rania (author), Jama, Hiba (author), Khalifa, Nisreen M. (author), Mohammed, Eiman M.A. (author)
منشور في:	2024
الوصول للمادة أونلاين:	http://hdl.handle.net/11675/12179 http://www.scopus.com/inward/record.url?scp=85183662845&partnerID=8YFLogxK
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients

مواد مشابهة